Skip to main content
. Author manuscript; available in PMC: 2009 Aug 1.
Published in final edited form as: Cancer Res. 2008 Aug 1;68(15):6208–6214. doi: 10.1158/0008-5472.CAN-07-6616

Table 3.

Impact of Sex, Age, Tumor Stage, Tumor Grade, and Smoking History on RUNX3 Methylation (PMR ≥ 10%, N=304)

OR (95% CI) p-value
Age at Diagnosis 0.0311
 1-Year Increase 1.04 (1.00, 1.08)
Sex 0.491
 Female 1.00 (reference)
 Male 1.23 (0.68, 2.20)
Tumor Stage & Grade 0.0101
 Ta - Low 1.00 (reference)
 Ta – High/CIS/T1 1.18 (0.68, 2.07)
 T2+ 2.16 (1.18, 3.94)
Smoking 0.0151
 Never/Irregular 1.00 (reference)
 Former/Current 2.76 (1.15, 6.66)
1

p-value based on likelihood ratio test.